The interaction of drugs with DNA is important for the discovery of novel drug molecules and for understanding the therapeutic effects of drugs as well as the monitoring of side effects. For this reason, many studies have been carried out to investigate the interactions of drugs with nucleic acids. In recent years, a large number of studies have been performed to electrochemically detect drug-DNA interactions. The fast, sensitive, and accurate results of electrochemical techniques have resulted in a leading role for their implementation in this field. By means of electrochemical techniques, it is possible not only to demonstrate drug-DNA interactions but also to quantitatively analyze drugs. In this context, electrochemical biosensors for drug-DNA interactions have been examined under different headings including anticancer, antiviral, antibiotic, and central nervous system drugs as well as DNA-targeted drugs. An overview of the studies related to electrochemical DNA biosensors developed for the detection of drug-DNA interactions that were reported in the last two decades in the literature is presented herein along with their applications and they are discussed together with their future perspectives.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760829PMC
http://dx.doi.org/10.55730/1300-0527.3584DOI Listing

Publication Analysis

Top Keywords

drug-dna interactions
16
electrochemical dna
8
dna biosensors
8
biosensors developed
8
drugs well
8
electrochemical techniques
8
drugs
7
electrochemical
5
interactions
5
developed monitoring
4

Similar Publications

The synthesis and characterization of benzo[d]thiazol-2-amine derivatives, which were prepared by reacting benzothiazole with para-aminobenzophenone in ethanol, supplemented with glacial acetic acid. Subsequently, compound (2) was synthesized from compound (1) using NaNO, HPO, and HNO in a water-based solvent, resulting in 2-hydroxy-1-naphthaldehyde. Another derivative, compound (3), was synthesized by reacting compound (1) with vanillin under similar conditions.

View Article and Find Full Text PDF
Article Synopsis
  • - Ofloxacin (OFL) and levofloxacin (LEV) are fluoroquinolone antibiotics effective against a wide range of bacteria by inhibiting DNA replication through binding to DNA gyrase.
  • - The study investigated how these antibiotics interact with calf thymus DNA using UV spectrophotometry and spectrofluorimetry, confirming their binding to DNA with specific binding constants.
  • - Thermodynamic properties, including Gibbs free energy, entropy, and enthalpy, were calculated to assess the spontaneity of the interactions, with results showing that both LEV-DNA and OFL-DNA interactions are spontaneous.
View Article and Find Full Text PDF

Metal-Based Drug-DNA Interactions and Analytical Determination Methods.

Molecules

September 2024

Department of Pharmaceutical Biochemistry and Clinical Laboratory, Faculty of Pharmacy, "Iuliu-Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Article Synopsis
  • * Binding mechanisms consist of covalent interactions (irreversible) like cross-linking, and non-covalent interactions (reversible) such as intercalation and groove binding.
  • * The review emphasizes DNA-metal complex interactions and outlines methods currently used to study these interactions.
View Article and Find Full Text PDF

A new three-dimensional modeling of fluorescence excitation-emission measurements to explore the interaction of hydroxychloroquine and DNA, and to quantify their binding constant.

Colloids Surf B Biointerfaces

January 2025

Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Yenimahalle 06560, Turkey; Department of Analytical Chemistry, Faculty of Pharmacy, Ankara Yıldırım Beyazıt University, Etlik, Ankara, Keçiören 06010, Turkey.

A new three-dimensional chemometric approach was introduced to explore the interaction of hydroxychloroquine (HCQ)-calf thymus deoxyribonucleic acid (DNA) and quantify binding constant using fluorescence excitation and emission measurements. The fluorescence excitation-emission spectra were recorded after gradual titration of HCQ with DNA. Then, the excitation and emission curves and relative concentrations of the drug and drug-DNA complex were quantitatively estimated using a three-dimensional model called Parallel Factor Analysis (PARAFAC) to a cubic fluorescence data array.

View Article and Find Full Text PDF

Trazodone (TZD) is an antidepressant drug used to treat major depressive and sleeping disorders. Elevated doses of trazodone are associated with central nervous system depression, which manifests as nausea, drowsiness, confusion, vertigo, exhaustion, etc. To develop a clinically viable active pharmaceutical compound with minimal adverse effects, it is imperative to possess a comprehensive knowledge of the drug's action mechanism on DNA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!